Factors Influencing Utilization of Different Types of Sulphonylureas Amongst Type 2 Diabetes Patients

被引：0
|
作者：
Huri, Hasniza Z. [1 ]
Wei, Amy T. -L. [1 ]
Pendek, Rokiah [2 ]
Sulaiman, Che Z. [3 ]
Widodo, Riyanto T. [1 ]
机构：
[1] Univ Malaya, Dept Pharm, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur 50603, Malaysia
[3] Univ Malaya, Med Ctr, Pharm Unit, Kuala Lumpur, Malaysia
来源：
LATIN AMERICAN JOURNAL OF PHARMACY | 2010年 / 29卷 / 06期
关键词：
Glibenclamide; Gliclazide; Glipizide; Sulphonylureas; Type 2 diabetes mellitus; OLDER PERSONS; INSULIN; HYPOGLYCEMIA; MELLITUS; FAILURE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Sulphonylureas (SUs) are commonly prescribed in Malaysia and also worldwide. However, very limited information is available on their pattern of use and appropriateness of its utilization. Age, concurrent use of drugs such as beta blocker, salicylate and frusemide and also renal impairment were found to have influence on the selection of different types of SUs.
引用
收藏
页码：1044 / 1048
页数：5
相关论文
共 50 条
  • [31] Establishment of models to predict factors influencing periodontitis in patients with type 2 diabetes mellitus
    Xu, Hong-Miao
    Shen, Xuan-Jiang
    Liu, Jia
    WORLD JOURNAL OF DIABETES, 2023, 14 (12)
  • [32] Clinical effectiveness of sitagliptin compared with sulphonylureas for type 2 diabetes
    Sharma, Manuj
    Nazareth, Irwin
    Petersen, Irene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 178 - 179
  • [33] What's the latest on sulphonylureas in the management of type 2 diabetes?
    Mkele, Gail
    SOUTH AFRICAN FAMILY PRACTICE, 2013, 55 (06) : 501 - 503
  • [34] What's the latest on sulphonylureas in the management of type 2 diabetes?
    Mkele, Gail
    SA PHARMACEUTICAL JOURNAL, 2013, 80 (05) : 12 - 14
  • [35] Factors influencing exercises in Chinese people with type 2 diabetes
    He, W.
    Zhang, Y.
    Zhao, F.
    INTERNATIONAL NURSING REVIEW, 2013, 60 (04) : 494 - 500
  • [36] Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes
    Wen, Li
    Duffy, Andrew
    JOURNAL OF NUTRITION, 2017, 147 (07): : 1468S - 1475S
  • [37] Factors influencing plasma homocysteine levels in type 2 diabetes
    Passaro, A
    D'Elia, K
    Pareschi, PL
    Calzoni, F
    Carantoni, M
    Fellin, R
    Solini, A
    DIABETES CARE, 2000, 23 (03) : 420 - 421
  • [38] Effect of an α-glucosidase inhibitor (voglibose), in combination with sulphonylureas, on glycaemic control in type 2 diabetes patients
    Saito, N
    Sakai, H
    Suzuki, S
    Sekihara, H
    Yajima, Y
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1998, 26 (05) : 219 - 232
  • [39] Severe hypoglycaemia during treatment with sulphonylureas in patients with type 2 diabetes in the Capital Region of Denmark
    Pilemann-Lyberg, S.
    Thorsteinsson, B.
    Snorgaard, O.
    Zander, M.
    Vestergaard, H.
    Roder, M. E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 110 (02) : 202 - 207
  • [40] Real world evidence on sulphonylureas use in Asian patients with type 2 diabetes - The JADE register
    Lima, L. L.
    Lau, E. S. H.
    Luk, A. O. Y.
    Durocher, A.
    Cortese, V.
    Chan, J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
12345